Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Inpixon

Start price
Target price
Perf. (%)
€8.33
17.10.22
-
17.10.23
-63.73%
29.10.22

Could be worthwhile Investment >10% per year
Very capable Management
Little innovation
buy
Schmitt Industries Inc.

Start price
Target price
Perf. (%)
€1.64
17.10.22
-
17.10.23
-99.97%
17.10.23

Probably not worthwhile Investment
Applied DNA Sciences Inc.

Start price
Target price
Perf. (%)
€2.38
15.10.22
€1.00
15.10.23
-24.07%
29.10.22

Significant cyclical dependencies
Little known brand
Revenue decline/stagnation expected
ROE lower than 10% per year
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€8.22
15.10.22
€0.000
15.10.23
2.13%
29.10.22

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€23.13
12.10.22
€62.00
12.01.27
51.23%
02.08.24

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very Future proof/growth oriented business model
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€23.13
12.10.22
€62.00
12.01.27
51.23%
02.08.24

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very Future proof/growth oriented business model
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€2.32
07.10.22
€5.00
07.10.23
-43.97%
08.10.23

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€4.10
04.10.22
-
04.10.23
14.15%
25.10.22

Probably not worthwhile Investment
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€28.02
03.10.22
€37.00
31.12.24
-26.25%
21.12.22

Could be worthwhile Investment >10% per year
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€28.02
03.10.22
€37.00
31.12.24
-26.25%
21.12.22

Could be worthwhile Investment >10% per year
buy
Amoeba S.A.

Start price
Target price
Perf. (%)
€0.86
01.10.22
-
01.10.23
-51.16%
02.10.23

Could be worthwhile Investment >10% per year
HelloFresh SE

Start price
Target price
Perf. (%)
€23.72
27.09.22
€20.00
27.09.23
-8.68%
01.10.22

Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€44.38
23.09.22
€25.00
31.12.24
-54.66%
05.05.23

Could be very worthwhile Investment >20% year
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€50.93
22.09.22
-
22.09.23
-56.29%
02.04.23

Risky Investment
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€0.78
21.09.22
€3.00
30.04.23
87.12%
06.02.23

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.18
20.09.22
€7.00
31.08.25
32.08%
05.05.23

Could be very worthwhile Investment >20% year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.20
19.09.22
-
19.09.23
-18.43%
08.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-3.77%
01.10.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.96
13.09.22
-
13.09.23
-17.60%
18.09.22

Could be worthwhile Investment >10% per year
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€29.73
13.09.22
-
13.09.23
20.64%
13.09.23

buy
Cameco Corp.

Start price
Target price
Perf. (%)
€29.73
13.09.22
-
13.09.23
20.64%
13.09.23

buy
Altimmune

Start price
Target price
Perf. (%)
€20.50
07.09.22
€38.00
30.04.25
-77.51%
05.05.23

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
26.85%
12.09.24

Could be very worthwhile Investment >20% year